by Waterley Pharma | Nov 15, 2023 | News Updates
Introduction: Insulin resistance has emerged as a crucial factor in predicting the development of NAFLD (Non-alcoholic fatty liver disease) among lean individuals, as highlighted in a recent study. This groundbreaking research, presented at the ACG 2023 Annual...
by Waterley Pharma | Nov 14, 2023 | News Updates
Evaluation and Management of Belching, Abdominal Bloating, and Distention: AGA Clinical Practice Update Belching, bloating, and abdominal distention are all highly prevalent gastrointestinal symptoms and account for some of the most common reasons for patient visits...
by Waterley Pharma | Jun 1, 2023 | News Updates
Nonalcoholic fatty liver disease (NAFLD) is a condition that is connected to obesity, metabolic syndrome, and heart disease. As NAFLD becomes more common, it is important to have easy and non-invasive tests to detect it. One test that shows promise is called Mean...
